Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 16

Economic Evaluation of Umeclidinium/Vilanterol versus Umeclidinium or Salmeterol in Symptomatic Non-Exacerbating Patients with COPD from a UK Perspective Using the GALAXY Model

Total article views   HTML views PDF downloads Totals
1,140 Dovepress* 1,140+ 47 1,187
Totals 1,140 47 1,187
*Since 13 November 2021

View citations on Google Scholar